Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07fda7432a787a6100ef0ace255965a4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6817 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6843 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c8df794b623e84e38baa3163f51c38 |
publicationDate |
2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2679266-A1 |
titleOfInvention |
Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
abstract |
Disclosed is a novel pharmaceutical composition comprising an anti-GRP78 antibody. Specifically disclosed are: a novel method for treatment of cancer using an anti-GRP78 antibody; a novel cell growth inhibitor or anti-cancer agent comprising an anti-GRP78 antibody; and a novel anti-GRP78 antibody. It is tried to produce an anti-tumor antibody targeting for GRP78 which localizes on a cell membrane in a cancer cell, and an anti-GRP78 antibody can be successfully produced which can bind specifically to the cell surface of a cancer cell. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9481735-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9481736-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663587-B2 |
priorityDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |